157 related articles for article (PubMed ID: 29890144)
21. Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.
Nicolussi S; Viveros-Paredes JM; Gachet MS; Rau M; Flores-Soto ME; Blunder M; Gertsch J
Pharmacol Res; 2014 Feb; 80():52-65. PubMed ID: 24412246
[TBL] [Abstract][Full Text] [Related]
22. Uroguanylin modulates (Na++K+)ATPase in a proximal tubule cell line: Interactions among the cGMP/protein kinase G, cAMP/protein kinase A, and mTOR pathways.
Arnaud-Batista FJ; Peruchetti DB; Abreu TP; do Nascimento NR; Malnic G; Fonteles MC; Caruso-Neves C
Biochim Biophys Acta; 2016 Jul; 1860(7):1431-8. PubMed ID: 27102282
[TBL] [Abstract][Full Text] [Related]
23. Cardiac glycoside downregulates NHE3 activity and expression in LLC-PK1 cells.
Oweis S; Wu L; Kiela PR; Zhao H; Malhotra D; Ghishan FK; Xie Z; Shapiro JI; Liu J
Am J Physiol Renal Physiol; 2006 May; 290(5):F997-1008. PubMed ID: 16352745
[TBL] [Abstract][Full Text] [Related]
24. Cell cycle-dependent and kinase-specific regulation of the apical Na/H exchanger and the Na,K-ATPase in the kidney cell line LLC-PK1 by calcitonin.
Chakraborty M; Chatterjee D; Gorelick FS; Baron R
Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2115-9. PubMed ID: 8134357
[TBL] [Abstract][Full Text] [Related]
25. CB1 receptors and post-ischemic brain damage: studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices.
Landucci E; Scartabelli T; Gerace E; Moroni F; Pellegrini-Giampietro DE
Neuropharmacology; 2011 Mar; 60(4):674-82. PubMed ID: 21130785
[TBL] [Abstract][Full Text] [Related]
26. GRP78/BIP is involved in ouabain-induced endocytosis of the Na/K-ATPase in LLC-PK1 cells.
Kesiry R; Liu J
Front Biosci; 2005 Sep; 10():2045-55. PubMed ID: 15970477
[TBL] [Abstract][Full Text] [Related]
27. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
Fidelman S; Mizrachi Zer-Aviv T; Lange R; Hillard CJ; Akirav I
Eur Neuropsychopharmacol; 2018 May; 28(5):630-642. PubMed ID: 29519609
[TBL] [Abstract][Full Text] [Related]
28. Pharmacologically different Na/H antiporters on the apical and basolateral surfaces of cultured porcine kidney cells (LLC-PK1).
Haggerty JG; Agarwal N; Reilly RF; Adelberg EA; Slayman CW
Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6797-801. PubMed ID: 2901105
[TBL] [Abstract][Full Text] [Related]
29. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
[TBL] [Abstract][Full Text] [Related]
30. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.
Slivicki RA; Xu Z; Mali SS; Hohmann AG
Pharmacol Res; 2019 Apr; 142():267-282. PubMed ID: 30739035
[TBL] [Abstract][Full Text] [Related]
31. Protective effect of fatty acid amide hydrolase inhibitor URB597 and monoacylglycerol lipase inhibitor KML29 on renal ischemia-reperfusion injury via toll-like receptor 4/nuclear factor-kappa B pathway.
Çakır M; Aydın A; Tekin S
Int Immunopharmacol; 2023 Jan; 114():109586. PubMed ID: 36700769
[TBL] [Abstract][Full Text] [Related]
32. Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 receptors located on glutamatergic neurons and on astrocytes.
Belluomo I; Matias I; Pernègre C; Marsicano G; Chaouloff F
J Neurochem; 2015 Apr; 133(1):26-37. PubMed ID: 25626460
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Na,K-ATPase activates PI3 kinase and inhibits apoptosis in LLC-PK1 cells.
Zhou X; Jiang G; Zhao A; Bondeva T; Hirszel P; Balla T
Biochem Biophys Res Commun; 2001 Jul; 285(1):46-51. PubMed ID: 11437370
[TBL] [Abstract][Full Text] [Related]
34. Characterization of ecto-ATPase activity in the surface of LLC-PK1 cells and its modulation by ischemic conditions.
Ribeiro MC; Costa-Alves MS; Wengert M; Meyer-Fernandes JR; Zancan P; Caruso-Neves C; Pinheiro AA
Biochim Biophys Acta; 2012 Dec; 1820(12):2030-6. PubMed ID: 23000490
[TBL] [Abstract][Full Text] [Related]
35. The endocannabinoid receptors CB1 and CB2 affect the regenerative potential of adipose tissue MSCs.
Ruhl T; Karthaus N; Kim BS; Beier JP
Exp Cell Res; 2020 Apr; 389(1):111881. PubMed ID: 32006556
[TBL] [Abstract][Full Text] [Related]
36. Protein kinase C-mediated ATP stimulation of Na(+)-ATPase activity in LLC-PK1 cells involves a P2Y2 and/or P2Y4 receptor.
Wengert M; Ribeiro MC; Abreu TP; Coutinho-Silva R; Leão-Ferreira LR; Pinheiro AA; Caruso-Neves C
Arch Biochem Biophys; 2013 Jul; 535(2):136-42. PubMed ID: 23567840
[TBL] [Abstract][Full Text] [Related]
37. Characterization of Na+-permeable cation channels in LLC-PK1 renal epithelial cells.
Raychowdhury MK; Ibarra C; Damiano A; Jackson GR; Smith PR; McLaughlin M; Prat AG; Ausiello DA; Lader AS; Cantiello HF
J Biol Chem; 2004 May; 279(19):20137-46. PubMed ID: 14982925
[TBL] [Abstract][Full Text] [Related]
38. Differential neuromodulatory role of endocannabinoids in the rodent trigeminal sensory ganglion and cerebral cortex relevant to pain processing.
Eroli F; Loonen ICM; van den Maagdenberg AMJM; Tolner EA; Nistri A
Neuropharmacology; 2018 Mar; 131():39-50. PubMed ID: 29225040
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.
Pascual AC; Gaveglio VL; Giusto NM; Pasquaré SJ
Exp Gerontol; 2014 Jul; 55():134-42. PubMed ID: 24768821
[TBL] [Abstract][Full Text] [Related]
40. The cannabinoid agonist WIN-2 affects acquisition but not consolidation of a spatial information in training and retraining processes: Relation with transcriptional regulation of the endocannabinoid system?
Alarcon TA; Areal LB; Herlinger AL; Paiva KK; Cicilini MA; Martins-Silva C; Pires RGW
Behav Brain Res; 2020 Jan; 377():112231. PubMed ID: 31526770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
